SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and ...

High blood sugar can complicate symptoms of Peyronie’s disease, and getting it under control may help you see improvements.

Not everyone with IgA nephropathy will need steroids, but for some, these medications can help protect kidney function. Here’s a closer look at the benefits, risks, and side effects.

Iptacopan is a complement factor B inhibitor targeting the overactive alternative complement pathway in IgA nephropathy.

Neuberg Diagnostics scientific session on renal focusses on precision-driven, patient-centric care: Our Bureau, Bengaluru Wednesday, April 1, 2026, 12:30 Hrs [IST] Neuberg Diagnos ...

In this episode, Overcoming Access Barriers and Step-Edit Challenges in IgA Nephropathy Care, the panelists explore the following questions: What barriers exist to real-world use, particularly around ...

Chronic diabetes mellitus is marked by hyperglycemia and metabolic dysfunction, increasing the risk of complications such as nephropathy. This study aimed to evaluate key biochemical parameters among ...

IgA nephropathy, first described in 1968 by Berger and Hinglais, 1 is the most common form of primary glomerulonephritis. For decades, IgA nephropathy was considered to have a relatively good ...

IgA nephropathy (IgAN) is a kidney condition where antibodies (immune system proteins) build up and cause damage in your kidneys. IgAN, also known as Berger's disease, does not have a cure. However, ...

The neutrophil-to-lymphocyte (NLR) ratio has shown potential as an inflammatory biomarker for identifying individuals at increased risk of diabetic nephropathy (DN) occurrence and progression. DN is ...

Diabetic nephropathy (DN) has become the primary cause of end-stage renal disease globally, and its epidemiological burden intensifies alongside the surging prevalence of diabetes. The pathogenesis ...

ABSTRACT: This study investigates the complex interactions between gut microbiota and the pathogenesis of type 2 diabetes mellitus (T2DM). T2DM, a prevalent metabolic disorder, is closely linked to ...